Home > Healthcare > Biotechnology > Bioservices > Genotyping Market

Genotyping Market Share

Report ID: GMI7567
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Genotyping Market Share

The market is characterized by diverse players competing in the industry. Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., and Danaher Corporation account for significant market share. These prominent players thrive through a combination of strategic initiatives, investing in research and development, geographical expansion, strategic approaches, product diversification, and regulatory compliance.

The foremost market players operating in the genotyping industry is as mentioned below:

Illumina Inc.
Thermo Fisher Scientific Inc.
QIAGEN N.V
F. Hoffmann-La Roche Ltd.
Standard BioTools Inc.
Danaher Corporation
Agilent Technologies, Inc.
Eurofins Scientific
GE Healthcare Technologies Inc.
Bio-Rad Laboratories Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Genotyping industry size reached USD 18.2 billion in 2022 and is set to exhibit 15.9% CAGR from 2023 to 2032 driven by the advent of high-throughput genotyping platforms to offer enhanced speed and accuracy of genetic testing.

Genotyping industry from the reagents & kits segment generated USD 8.3 billion in revenue in 2022 and is estimated to record substantial growth through 2032 due to surging demand to facilitate accurate and high-throughput genotyping processes.

North America held 41.4% revenue share of the genotyping market in 2022 and is estimated to expand at a notable CAGR attributed to the technological advancements, increasing R&D activities, and the growing demand for personalized medicine.

Some of the major genotyping firms are Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN N.V, F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Inc., GE Healthcare Technologies Inc., and Bio-Rad Laboratories Inc., among others.